Use of Endotracheal Tube Cuff Pressure to Assess Inspiratory Effort During Pressure Support Ventilation

NCT ID: NCT06968793

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-20

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During pressure support ventilation (PSV), monitoring of Esophageal Pressure (Pes) has long been considered the gold standard for assessing intrathoracic pressure and the state of respiratory mechanics.The aim of this study was to investigate the correlation between Cuff Pressure (Pcuff) and Esophageal Pressure in patients undergoing tracheal intubation or tracheotomy, and to assess whether Pcuff can be used as a surrogate for Pes for reflecting changes in intrathoracic pressure.The correlation and its consistency between the two under different ventilation conditions were analysed by synchronously monitoring the ΔPcuff and ΔPes to further validate the potential application value of cuff pressure in clinical practice.The results of the study will provide a more convenient and non-invasive method of monitoring intrathoracic pressure in mechanically ventilated patients, thus optimising ventilation strategies, reducing complications, and promoting the innovation and development of monitoring technology in the field of critical care medicine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Monitoring of Esophageal pressure (Pes) has long been regarded as the gold standard for assessing intrathoracic pressure and respiratory mechanics. The measurement of Esophageal pressure provides indirect information about pleural pressure, which is critical for understanding respiratory mechanics, optimizing mechanical ventilation strategies, and evaluating respiratory muscle load.

However, despite its clinical significance, Esophageal pressure monitoring involves a relatively complex and invasive procedure. Measurement typically requires the insertion of an esophageal catheter via the nasopharyngeal or oropharyngeal route, which may cause patient discomfort and prove challenging in certain cases (e.g., esophageal pathologies or anatomical abnormalities). Consequently, while esophageal pressure remains the current gold standard for evaluating intrathoracic pressure, its clinical application faces limitations.

In contrast, Cuff pressure (Pcuff) monitoring in intubated or tracheostomized patients is simpler and routinely performed. Cuff pressure measurement primarily ensures tracheal tube sealing to prevent gas leakage and aspiration, while also reducing the risk of ventilator-associated pneumonia (VAP). Our preliminary exploratory studies have revealed correlations between Cuff pressure fluctuations and Esophageal pressure, particularly in patients undergoing pressure support ventilation. This finding suggests the potential utility of Cuff pressure as a surrogate marker for intrathoracic pressure. Esophageal pressure inherently reflects pleural pressure through Esophageal pressure changes, while the artificial airway cuff-positioned above the carina within the trachea-detects subtle pressure variations induced by adjacent muscle activity during forceful breathing. These measurements may indirectly indicate inspiratory effort. Variations in cuff positioning might influence results, and our exploratory attempts demonstrated strong waveform correlations between Cuff pressure and Esophageal pressure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mechanical Ventilation Critical Care Inspiratory Effort

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pressure support 15

Pressure support of 15 cm H2O will be applied for 5 minutes.

Group Type EXPERIMENTAL

Pressure support 15

Intervention Type PROCEDURE

Pressure support of 15 cm H2O will be applied for 5 minutes.

Pressure support 13

Pressure support of 13 cm H2O will be applied for 5 minutes.

Group Type EXPERIMENTAL

Pressure support 13

Intervention Type PROCEDURE

Pressure support of 13 cm H2O will be applied for 5 minutes.

Pressure support 11

Pressure support of 11 cm H2O will be applied for 5 minutes.

Group Type EXPERIMENTAL

Pressure support 11

Intervention Type PROCEDURE

Pressure support of 11 cm H2O will be applied for 5 minutes.

Pressure support 9

Pressure support of 9 cm H2O will be applied for 5 minutes.

Group Type EXPERIMENTAL

Pressure support 9

Intervention Type PROCEDURE

Pressure support of 9 cm H2O will be applied for 5 minutes.

Pressure support 7

Pressure support of 7 cm H2O will be applied for 5 minutes.

Group Type EXPERIMENTAL

Pressure support 7

Intervention Type PROCEDURE

Pressure support of 7 cm H2O will be applied for 5 minutes.

Pressure support 5

Pressure support of 5 cm H2O will be applied for 5 minutes.

Group Type EXPERIMENTAL

Pressure support 5

Intervention Type PROCEDURE

Pressure support of 5 cm H2O will be applied for 5 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pressure support 15

Pressure support of 15 cm H2O will be applied for 5 minutes.

Intervention Type PROCEDURE

Pressure support 13

Pressure support of 13 cm H2O will be applied for 5 minutes.

Intervention Type PROCEDURE

Pressure support 11

Pressure support of 11 cm H2O will be applied for 5 minutes.

Intervention Type PROCEDURE

Pressure support 9

Pressure support of 9 cm H2O will be applied for 5 minutes.

Intervention Type PROCEDURE

Pressure support 7

Pressure support of 7 cm H2O will be applied for 5 minutes.

Intervention Type PROCEDURE

Pressure support 5

Pressure support of 5 cm H2O will be applied for 5 minutes.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Mechanically ventilated patients who can tolerate pressure support ventilation (PSV) mode;
2. Respiratory stability: Ability to breathe spontaneously and effectively clear secretions via coughing; oxygen saturation (SpO₂) \>90% or a partial pressure of oxygen (PaO₂)/FiO₂ ratio ≥150 mmHg when the ventilator's oxygen concentration is set to 40%;
3. Hemodynamic stability: Heart rate (HR) ≤120 bpm, systolic blood pressure (SBP) 90-150 mmHg, with no vasoactive agents or norepinephrine dosage ≤0.1-0.2 μg/kg·min (or equivalent doses of other vasoactive agents);
4. Metabolic stability, with an esophageal pressure monitoring catheter already placed prior to the trial;
5. Written informed consent obtained from the patient or their legal guardian.

Exclusion Criteria

1. Age \<18 years;
2. Pregnancy;
3. Hemodynamic instability: Mean arterial pressure (MAP) \<60 mmHg, heart rate (HR) \>120 bpm or \<60 bpm;
4. Respiratory instability: Respiratory rate (RR) \>35 bpm or oxygen saturation (SpO₂) \<90%;
5. Neuromuscular disorders or phrenic nerve injury;
6. Recent trauma or surgery involving the trachea, esophagus, neck, or thorax, contraindications to esophageal catheter insertion, or inability to monitor esophageal pressure;
7. High bleeding risk: Severe coagulopathy/bleeding disorders, esophageal/gastric varices, etc.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jian-Xin Zhou

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jian-Xin Zhou

Head of Emergency and Critical Care Center

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jian-Xin Zhou, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Capital Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Shijitan Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IIT2025-034-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of End-inspiratory Pause on Ventilation
NCT06692634 NOT_YET_RECRUITING NA